Ralph Schwall

12.7k total citations · 3 hit papers
85 papers, 10.2k citations indexed

About

Ralph Schwall is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Ralph Schwall has authored 85 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 25 papers in Hepatology and 12 papers in Oncology. Recurrent topics in Ralph Schwall's work include TGF-β signaling in diseases (29 papers), Liver physiology and pathology (25 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Ralph Schwall is often cited by papers focused on TGF-β signaling in diseases (29 papers), Liver physiology and pathology (25 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Ralph Schwall collaborates with scholars based in United States, France and Switzerland. Ralph Schwall's co-authors include Anthony J. Mason, Hartmut Koeppen, Sharon Fong, Avi Ashkenazi, David A. Lawrence, Andrea Hebert, Scot A. Marsters, Iphigenia L. Koumenis, Ling Chang and Susan W.S. Leung and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ralph Schwall

85 papers receiving 9.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and antitumor activity of recombinant soluble Apo2 ligand

1999 1.9k citations Hartmut Koeppen, Ralph Schwall et al. profile →
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

2008 1.3k citations Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research profile →
Vascular endothelial growth factor is essential for corpus luteum angiogenesis

1998 513 citations Ralph Schwall et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ralph Schwall	6.1k	2.7k	1.5k	1.4k	1.4k	85	10.2k
Joost J. van den Oord	2.8k 0.5×	1.9k 0.7×	691 0.5×	565 0.4×	1.8k 1.3×	167	7.8k
Pier Giorgio Natali	5.3k 0.9×	3.1k 1.2×	363 0.2×	1.7k 1.2×	2.6k 1.9×	260	11.3k
David Danielpour	5.8k 1.0×	1.8k 0.7×	250 0.2×	646 0.5×	1.3k 0.9×	135	9.5k
Olga V. Volpert	8.4k 1.4×	2.3k 0.9×	333 0.2×	964 0.7×	1.3k 1.0×	107	12.5k
Eiji Miyoshi	9.0k 1.5×	1.9k 0.7×	990 0.7×	1.7k 1.2×	4.5k 3.2×	311	12.5k
Jürgen Behrens	15.5k 2.5×	3.8k 1.4×	963 0.7×	288 0.2×	1.0k 0.7×	113	19.3k
Ermanno Gherardi	6.4k 1.1×	2.1k 0.8×	5.4k 3.7×	961 0.7×	1.1k 0.8×	108	11.6k
Malcolm Alison	4.4k 0.7×	2.5k 0.9×	2.8k 1.9×	280 0.2×	747 0.5×	184	10.7k
Noël Bouck	9.5k 1.6×	2.9k 1.1×	271 0.2×	1.2k 0.8×	1.2k 0.9×	93	13.8k
Yuen Shing	7.1k 1.2×	1.9k 0.7×	367 0.3×	650 0.5×	679 0.5×	57	10.4k

Countries citing papers authored by Ralph Schwall

Since Specialization

Citations

This map shows the geographic impact of Ralph Schwall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Schwall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Schwall more than expected).

Fields of papers citing papers by Ralph Schwall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Schwall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Schwall. The network helps show where Ralph Schwall may publish in the future.

Co-authorship network of co-authors of Ralph Schwall

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Schwall. A scholar is included among the top collaborators of Ralph Schwall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Schwall. Ralph Schwall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Phillips, Gail D. Lewis, Guangmin Li, Debra L. Dugger, et al.. (2008). Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate. Cancer Research. 68(22). 9280–9290. 1259 indexed citations breakdown →

Dennis, Mark S., Hongkui Jin, Debra L. Dugger, et al.. (2007). Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent. Cancer Research. 67(1). 254–261. 204 indexed citations

Kong-Beltran, Monica, Somasekar Seshagiri, Jiping Zha, et al.. (2006). Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer. Cancer Research. 66(1). 283–289. 372 indexed citations

Crocker, Lisa, Gail D. Lewis Phillips, Brian Reardon, et al.. (2005). Evolution of the MDA-MB-175 breast cancer cell line from a low to a high HER2 expressing tumor line. Cancer Research. 65. 253–253. 1 indexed citations

Schwall, Ralph, Zhong Zheng, Elaine Mai, et al.. (2004). Inhibition of cMet activation by a one-armed antibody. Cancer Research. 64. 327–327. 10 indexed citations

Finkle, David, Vida Asghari, Elaine Mai, et al.. (2004). HER2-Targeted Therapy Reduces Incidence and Progression of Midlife Mammary Tumors in Female Murine Mammary Tumor Virus huHER2-Transgenic Mice. Clinical Cancer Research. 10(7). 2499–2511. 91 indexed citations

Mendoza, Nerissa, et al.. (2002). Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.. PubMed. 62(19). 5485–8. 68 indexed citations

Rubin, Jeffrey S., Regina M. Day, Neşe Atabey, et al.. (2001). Dissociation of Heparan Sulfate and Receptor Binding Domains of Hepatocyte Growth Factor Reveals That Heparan Sulfate-c-Met Interaction Facilitates Signaling. Journal of Biological Chemistry. 276(35). 32977–32983. 86 indexed citations

Ohashi, Kazuhiko, Leonard Meuse, Ralph Schwall, & Mark A. Kay. (2001). cMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice. Transplantation Proceedings. 33(1-2). 587–588. 8 indexed citations

10.

Perez‐Stable, Carlos, Ralph Schwall, Kerry L. Burnstein, et al.. (2000). Hepatocyte Growth Factor and Vitamin D Cooperatively Inhibit Androgen-Unresponsive Prostate Cancer Cell Lines*. Endocrinology. 141(7). 2567–2573. 16 indexed citations

11.

Wilson, Steven E., Rajiv R. Mohan, Timo Tervo, et al.. (1998). Lacrimal Gland Growth Factors and Receptors: Lacrimal Fibroblastic Cells are a Source of Tear HGF. Advances in experimental medicine and biology. 438. 625–628. 9 indexed citations

12.

Jin, Liang, Ren Yuan, Alexander Fuchs, et al.. (1997). Expression of interleukin-1? in human breast carcinoma. Cancer. 80(3). 421–434. 138 indexed citations

13.

Rahimi, Nader, et al.. (1996). Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.. PubMed. 7(2). 263–70. 60 indexed citations

14.

Richardson, Louise, Ralph Schwall, & Thomas F. Zioncheck. (1996). Hepatocyte Growth Factor/Scatter Factor: Structure, Function and Regulation by Glycosaminoglycans.. Trends in Glycoscience and Glycotechnology. 8(41). 167–182. 24 indexed citations

15.

Zioncheck, Thomas F., Louise Richardson, Jun Liu, et al.. (1995). Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic Activity. Journal of Biological Chemistry. 270(28). 16871–16878. 147 indexed citations

16.

Schwall, Ralph. (1993). Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology. 18(2). 347–356. 173 indexed citations

17.

Lofgren, James A., Ralph Schwall, Charles H. Schmelzer, & Wai Lee Wong. (1991). Generation of Polyclonal Antibodies Against Recombinant Human Activin a. Journal of Immunoassay. 12(4). 565–578. 2 indexed citations

18.

DePaolo, Louis V., Motoyuki Shimonaka, Ralph Schwall, & Nicholas Ling. (1991). In VivoComparison of the Follicle-Stimulating Hormone-Suppressing Activity of Follistatin and Inhibin in Ovariectomized Rats*. Endocrinology. 128(2). 668–674. 31 indexed citations

19.

McLachlan, Robert I., Kristine D. Dahl, William J. Bremner, et al.. (1989). Rccombinant human activin-A stimulates basal FSH and GnRH-stimulated FSH and LH release in the adult male macaque, Macaca fascicularis. Endocrinology. 125(5). 2787–2789. 41 indexed citations

20.

Schwall, Ralph, Károly Nikolics, Éva Szönyi, Cori Gorman, & Anthony J. Mason. (1988). Recombinant Expression and Characterization of Human Activin A. Molecular Endocrinology. 2(12). 1237–1242. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact